Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 9, 2013, Pages 1663-1668

  Lowe, G C ^a   Lordkipanidze M ^a   Watson, S P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Blood platelet disorders; Coagulation disorders, inherited; Decision support techniques; Platelet aggregation; Platelet function tests

Indexed keywords

ADULT; ARTICLE; BLEEDING; CLINICAL ASSESSMENT TOOL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUMAN; INTERNATIONAL SOCIETY ON THROMBOSIS AND HEMOSTASIS BLEEDING ASSESSMENT TOOL; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL PARAMETERS; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; THROMBOCYTE ACTIVATION; THROMBOCYTE ANOMALY; THROMBOCYTE DISORDER; THROMBOCYTE FUNCTION;

BLOOD PLATELET DISORDERS; COAGULATION DISORDERS, INHERITED; DECISION SUPPORT TECHNIQUES; PLATELET AGGREGATION; PLATELET FUNCTION TESTS;

BLOOD PLATELET DISORDERS; CASE-CONTROL STUDIES; HEMORRHAGE; HUMANS;

EID: 84883786964     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12332     Document Type: Article

References (17)

1. Rydz N, James PD. The evolution and value of bleeding assessment tools. J Thromb Haemost 2012; 10: 2223-9.
2. Rodeghiero F, Castaman G, Tosetto A, Batlle J, Baudo F, Cappelletti A, Casana P, De Bosch N, Eikenboom JC, Federici AB, Lethagen S, Linari S, Srivastava A. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005; 3: 2619-26.
3. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, Meyer D, Fressinaud E, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4: 766-73.
4. Katsanis E, Luke KH, Hsu E, Li M, Lillicrap D. Prevalence and significance of mild bleeding disorders in children with recurrent epistaxis. J Pediatr 1988; 113: 73-6.
5. Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR, Siekmann J, Turecek PL, Lillicrap D, Rand ML. von Willebrand disease in a pediatric-based population - comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thromb Haemost 2000; 84: 401-9.
6. Bowman M, Riddel J, Rand ML, Tosetto A, Silva M, James PD. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost 2009; 7: 1418-21.
7. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97: 734-9.
8. Philipp CS, Faiz A, Heit JA, Kouides PA, Lukes A, Stein SF, Byams V, Miller CH, Kulkarni R. Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia. Am J Obstet Gynecol 2011; 204: 209e1-7.
9. Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 8: 2063-5.
10. Bidlingmaier C, Grote V, Budde U, Olivieri M, Kurnik K. Prospective evaluation of a pediatric bleeding questionnaire and the ISTH bleeding assessment tool in children and parents in routine clinical practice. J Thromb Haemost 2012; 10: 1335-41.
11. Dawood BB, Lowe GC, Lordkipanidzé M, Bem D, Daly ME, Makris M, Mumford A, Wilde JT, Watson SP. Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood 2012; 120: 5041-9.
12. Meade TW, Vickers MV, Thompson SG, Stirling Y, Haines AP, Miller GJ. Epidemiological characteristics of platelet aggregability. Br Med J (Clin Res Ed) 1985; 290: 428-32.
13. Rodeghiero F, Castaman G. Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessment. Best Pract Res Clin Haematol 2001; 14: 321-35.
14. Watson SP, Lowe GC, Lordkipanidze M, Morgan NV. Genotyping and phenotyping of platelet function disorders. J Thromb Haemost 2013; 11 (Suppl. s1): 351-63.
15. Rodeghiero F, Tosetto A, Castaman G. How to estimate bleeding risk in mild bleeding disorders. J Thromb Haemost 2007; 5(Suppl. 1): 157-66.
16. Tosetto A, Castaman G, Plug I, Rodeghiero F, Eikenboom J. Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation. J Thromb Haemost 2011; 9: 1143-8.
17. International Society on Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH-BAT). ISTH-BATR. https://bh.rockefeller.edu/ISTH-BATR/. Accessed 9 April 2013.